| Application no. and date | 92112371.7 (espacenet) (Federated) (European Patent Register), 19920720 | | Patent/reg. no. and date | DK/EP 0524579, 19980311 | | Publication date | 19930127 | | Priority no. and date | US 733547, 19910722, US 882204, 19920513 | | EP pub. no. and date |
EP 0524579 19930127 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, 345 Park Avenue
New York, N.Y. 10154, US | | Applicant ref. no. | 26860 | | Inventor | Ullah, Ismat, 5024 Platinum Drive, Liverpool, New York 13088 , US,
Agharkar, Shreeram Narahari, 7290 Wakefield Drive, Fayetteville, New York 13066 , US,
Wiley, Gary James, 2416 Sourwood Drive, Phoenix, New York 13135 , US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 33/06, A61K 33/08, A61K 33/10, A61K 9/00, A61K 9/20, A61K 31/70 | | Title | Forbedrede orale dosisformuleringer af dideoxypurinnukleosider | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
